ORAGENICS INC

OGEN · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 3 employees
447
SEC Filings
$0.201
Close 2026-11-13
3
Employees

Business Summary

Oragenics Inc. is a development-stage biopharmaceutical company focused on nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. Its lead product, ONP-002, is a fully synthetic neurosteroid administered via a novel intranasal breath-powered device, designed to treat mild traumatic brain injury (mTBI/concussion) by reducing swelling, oxidative stress, and inflammation while restoring blood flow through gene amplification. ONP-002 has completed Phase 1 clinical trials in Australia and is targeting Phase 2a initiation in Q1 2026.

Latest Stock Quote

OGEN 2026-11-13 $0.201 O:$0.2112 H:$0.2266 L:$0.1667 Vol:17.5M VWAP:$0.2431
origin leaf: null

Next Earnings

expected 2026-12-16

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001493152-26-010282EDGAR78K words
2025-03-142024-12-310001493152-25-010389EDGAR85K words
2024-03-292023-12-310001493152-24-011979EDGAR93K words
2023-04-172022-12-310001493152-23-012617EDGAR110K words
2022-03-242021-12-310001493152-22-007664EDGAR105K words
2021-03-012020-12-310001493152-21-005122EDGAR110K words
2020-03-042019-12-310001493152-20-003343EDGAR98K words
2019-03-292018-12-310001564590-19-010173EDGAR82K words
2018-02-162017-12-310001193125-18-048564EDGAR102K words
2017-02-272016-12-310001193125-17-058912EDGAR96K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-122026-09-300001493152-26-051477EDGAR19K words
2026-08-132026-06-300001493152-26-037749EDGAR17K words
2025-11-072025-09-300001493152-25-021257EDGAR15K words
2025-08-082025-06-300001641172-25-022766EDGAR15K words
2025-05-092025-03-310001641172-25-009464EDGAR12K words
2024-11-132024-09-300001493152-24-045067EDGAR22K words
2024-08-092024-06-300001493152-24-031000EDGAR19K words
2024-05-152024-03-310001493152-24-019655EDGAR18K words
2023-11-092023-09-300001493152-23-040060EDGAR27K words
2023-08-112023-06-300001493152-23-027838EDGAR25K words
2023-05-122023-03-310001493152-23-016708EDGAR22K words
2022-11-142022-09-300001493152-22-032121EDGAR22K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-160001493152-26-042843EDGAR0K words
2026-08-280001493152-26-040645EDGAR1K words
2026-03-310001493152-26-014128EDGAR1K words
2026-03-110001493152-26-009682EDGAR1K words
2026-01-220001493152-26-003237EDGAR1K words
2026-01-200001493152-26-002759EDGAR0K words
2025-12-150001493152-25-027745EDGAR1K words
2025-11-120001493152-25-021749EDGAR2K words
2025-10-210001493152-25-018725EDGAR1K words
2025-09-020001493152-25-012562EDGAR1K words

447 total filings indexed. 415 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

mild-traumatic-brain-injury-(mtbi/concussion)-treatment neurological-conditions infectious-diseases intranasal-drug-delivery glp-(good-laboratory-practice)-toxicology-studies ind-(investigational-new-drug)-application-process sad/mad-(single-ascending-dose/multiple-ascending-dose)-clinical-trial-design certificate-of-analysis-(coa)-manufacturing-standards herg-tail-current-safety-pharmacology-testing

Company Identity

CIK0001174940
TickerOGEN
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedFL
Websitehttps://www.oragenics.com
Listed2003-07-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: e44e94e9f8447e6958a8e0a3441f7d9f1db8e6bd1612491ac10d3f0f7e45a975
parent: 8d1edc5c471403553dba602d66071b9b198ccb5fc31e5d8ff395a1b0b1a93311
content hash: 657d19378ae124042003cf159d0a9a3451f35e6ca06fca9aada7816d983027ef
signed: 2026-11-16T19:03:58.130Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up OGEN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on OGEN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/OGEN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.